League Connect Digital Summit is WEDNESDAY

It’s Matthew Holt and I am looking forward to MC-ing the #LeagueConnectDigitalSummit THIS Wednesday May 7. This one-day virtual event brings together leaders across health care, tech, and consumer experience to explore what it really takes to deliver personalized, digital-first, AI-powered care. I’ll be guiding the day’s key transitions and themes. There’s also strategy &…

Read More

Après AI, le Déluge

By KIM BELLARD I have to admit, I’ve steered away from writing about AI lately. There’s just so much going on, so fast, that I can’t keep up. Don’t ask me how GPT-5 differs from GPT-4, or what Gemini does versus Genie 3. I know Microsoft really, really wants me to use Copilot, but so…

Read More

Nektar’s Novel Eczema Drug Meets Trial Goals, But Differentiation From Dupixent Remains Unclear

Nektar Therapeutics’ biologic drug rezpegaldesleukin take a new approach to atopic dermatitis, or eczema, stimulating proliferation of immune cells that tamp down excessive immune responses. The drug met the goals of a Phase 2b study, but analysts note that cross-trial measures show those results are short of the marks achieved by Dupixent, the top biologic…

Read More